Avient vs Hexcel
AVNT and HXL side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AVNT and HXL compare
Hexcel is the larger company, worth 1.4 times as much as Avient ($5.8B against $4.0B).
On earnings, Avient is cheaper: it trades at 23.5× trailing earnings, against 34.3× for Hexcel.
Hexcel grew revenue faster over the last twelve months (7.6% versus 2.4% for Avient).
Hexcel keeps more of each dollar of sales as profit, with a net margin of 8.5% compared with 5.1% at Avient.
Both pay dividends: Avient yields 2.5% and Hexcel 0.71%.
Hexcel scores higher on the StockData Score (14 against 12 for Avient), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AVNT | HXL |
|---|---|---|
| Size and price | ||
| Market cap | $4.0B | $5.8B |
| Share price | $43.54 | $76.42 |
| Change, 1 year | 48.7% | 10.6% |
| Change, 5 years | −24.1% | 43.5% |
| Beta (5Y) | 0.84 | 0.69 |
| Employees | 9,000 | 5,563 |
| StockData Score | ||
| Total score | 12 | 14 (better) |
| Valuation score | 2 | 2 |
| Growth score | 2 | 3 (better) |
| Performance score | 2 | 2 |
| Health score | 2 | 4 (better) |
| Dividend score | 4 (better) | 3 |
| Valuation | ||
| P/E | 23.5× (better) | 34.3× |
| P/S | 1.2× (better) | 2.9× |
| P/B | 1.6× (better) | 4.4× |
| EV/EBITDA | 10.8× (better) | 18.1× |
| P/FCF | 20.9× (better) | 27.6× |
| FCF yield | 4.8% (better) | 3.6% |
| Fair value | $44.89 | $68.15 |
| Margin of safety | 3.0% (better) | −12.1% |
| Growth | ||
| Revenue growth (TTM) | 2.4% | 7.6% (better) |
| Revenue growth, 5Y average | 8.0% (better) | 4.7% |
| Net income growth (TTM) | 43.0% | 149% (better) |
| EPS growth (TTM) | 43.4% | 162% (better) |
| EPS growth, 5Y average | −9.3% | – |
| Profitability | ||
| Gross margin | 31.7% (better) | 25.2% |
| Operating margin | 9.5% | 12.2% (better) |
| Net margin | 5.1% | 8.5% (better) |
| FCF margin | 5.7% | 10.4% (better) |
| Return on equity | 7.1% | 11.9% (better) |
| Return on invested capital | 6.1% | 8.8% (better) |
| Financial health | ||
| Debt / equity | 0.77 | 0.71 (better) |
| Net debt / EBITDA | 2.87 | 2.33 (better) |
| Interest coverage | – | 5.2× |
| Current ratio | 1.90 | 2.57 (better) |
| Altman Z-score | 1.55 | 4.95 (better) |
| Piotroski F-score | 6 | 6 |
| Dividends and buybacks | ||
| Dividend yield | 2.5% (better) | 0.71% |
| Payout ratio | 58.7% | 31.4% |
| Years of dividend growth | 15 (better) | 3 |
| Dividend growth, 5Y average | 5.8% | 32.0% (better) |
| Buyback yield | – | 6.1% |
| Shareholder yield | 2.5% | 6.8% (better) |
| Ownership | ||
| Held by institutions | 105% | 114% |
| Held by insiders | 0.83% | 1.0% |
| Insider net buying, 12 months | – | −$2.1M |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 4.7% | 7.1% |
Go deeper
- AVNT stock overview
- AVNT income statement
- AVNT valuation and score
- HXL stock overview
- HXL income statement
- HXL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.